Back
Rhythm Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
RYTM
Rhythm Pharmaceuticals
Last Price:
$55.40
Seasonality Move:
-16.51%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing slight buying pressure.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.77 | Sell |
| 20-day SMA: | 57.23 | Sell |
| 50-day SMA: | 56.59 | Sell |
| 200-day SMA: | 47.2 | Buy |
| 8-day EMA: | 55.99 | Sell |
| 20-day EMA: | 56.74 | Sell |
| 50-day EMA: | 56 | Sell |
| 200-day EMA: | 48.47 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 45.52 | Sell |
| Chaikin Money Flow: | 4855 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.5 - 60.32) | Sell |
| Bollinger Bands (100): | (46.93 - 58.21) | Buy |
Rhythm Pharmaceuticals Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 55.59 while RYTM 8-day simple moving average is 55.77, which is a Sell signal.
-
The stock price of RYTM is 55.59 while Rhythm Pharmaceuticals 20-day SMA is 57.23, which makes it a Sell.
-
Rhythm Pharmaceuticals 50-day simple moving average is 56.59 while RYTM share price is 55.59, making it a Sell technically.
-
RYTM stock price is 55.59 and Rhythm Pharmaceuticals 200-day simple moving average is 47.20, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Sell
44
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a SellThe current Rhythm Pharmaceuticals [RYTM] share price is $55.59. The Score for RYTM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.4B
Price in USD:
55.59
Share Volume:
237.9K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
68.58
52-Week Low:
35.17
Sell
44
Rhythm Pharmaceuticals (RYTM)
is a Sell
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?The Rhythm Pharmaceuticals stock price is 55.59 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 55.59 while RYTM 8-day exponential moving average is 55.99, which is a Sell signal.
-
The stock price of RYTM is 55.59 while Rhythm Pharmaceuticals 20-day EMA is 56.74, which makes it a Sell.
-
Rhythm Pharmaceuticals 50-day exponential moving average is 56.00 while RYTM share price is 55.59, making it a Sell technically.
-
RYTM stock price is 55.59 and Rhythm Pharmaceuticals 200-day simple moving average is 48.47, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.77 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is -0.56, suggesting Rhythm Pharmaceuticals is a Sell
-
Rhythm Pharmaceuticals Relative Strength Index (RSI) is 45.52, which suggest Rhythm Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals is (55.5 - 60.32), which suggest Rhythm Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals is (46.93 - 58.21), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.